Viridian Therapeutics (VRDN) announced the appointment of Sarah Gheuens, M.D., Ph.D., to its Board of Directors. Dr. Gheuens is the Chief Medical Officer, CMO, and Head of R&D of Agios Pharmaceuticals (AGIO)
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on VRDN:
